Levicept Presents New Data Suggesting a Novel Neurotrophin-3 Inhibitor, LEVI-04, May Modify Disease and Improve Symptoms in Osteoarthritis

In a Phase II trial, LEVI-04 demonstrated a significant, dose-dependent reduction in bone marrow lesions (BML) compared with placebo in patients ...
Medical Dialogues

Medical Bulletin 27/October/2025 - Video

Common cholesterol-lowering drugs may reduce risk of developing dementia: StudyLower cholesterol levels may play a key role ...